Month: September 2017

Quanta News

Quanta unveils SC+ dialysis system

Seroba’s investee company, Quanta Dialysis Technologies Ltd, a medical device company providing innovative haemodialysis solutions for the clinic and the home, has unveiled at the 10th UK Annual Dialysis Conference in Manchester, UK, its SC+ personal haemodialysis system for market launch next year. Based on clinical experience obtained during Quanta’s extensive pilot studies, which included …

Quanta unveils SC+ dialysis system Read More »

Fusion News

Seroba Invests in Fusion Pharmaceuticals

Hamilton, Ontario, September 25, 2017. Fusion Pharmaceuticals, a clinical-stage biopharmaceutical company developing targeted alpha-particle radiotherapeutics for treating cancer, today announced it has completed a second closing of its Series A financing, securing an additional $21 million USD in capital and bringing the total capital raised to $46 million USD. New investors in the second closing …

Seroba Invests in Fusion Pharmaceuticals Read More »

Novate News

Novate Filter Yields Zero Pulmonary Embolisms at 12 Months

Galway, Ireland – 12 September 2017.  Clinical trial results for Novate’s SENTRY device have been presented by Principal Investigator, Michael Dake MD of Stanford University in California at the 15th Annual Conference on Vascular Interventional Advances (VIVA17), which has been taking place this week in Las Vegas, Nevada, USA. SENTRY is a prospective, single-arm, multi-centre registry trial …

Novate Filter Yields Zero Pulmonary Embolisms at 12 Months Read More »

Pq Bypass

PQ Bypass Unveils New Data From DETOUR I at VIVA 17

Seroba’s investee company, PQ Bypass, today announced data from a subset analysis of the DETOUR I clinical trial during a late-breaking clinical trial session at Vascular InterVentional Advances (VIVA 17), which is taking place September 11-14 in Las Vegas. The study evaluated the safety and effectiveness of the DETOUR System for treating long-segment (>25cm) blockages …

PQ Bypass Unveils New Data From DETOUR I at VIVA 17 Read More »

Biomimics 3d

Mimics Study’s Outcomes Announced at VIVA17

Professor Thomas Zeller MD announced new significant outcomes from the Mimics Study today at the 15th Annual Conference on Vascular Interventional Advances (VIVA17) in Las Vegas, NV, USA. The BioMimics 3D Vascular Stent with unique helical curvature to generate swirling blood flow was evaluated in the Mimics Study, which randomised 76 patients with symptomatic peripheral …

Mimics Study’s Outcomes Announced at VIVA17 Read More »

T: 353 (0)1 633 4028

18 Herbert Street
Dublin 2
D02 FK19
Ireland

Scroll to Top